Literature DB >> 1847691

MHC class II-restricted T-cell hybridomas recognizing the nucleocapsid protein of avian coronavirus IBV.

A M Boots1, M J Van Lierop, J G Kusters, P J Van Kooten, B A Van der Zeijst, E J Hensen.   

Abstract

Mice were immunized with purified infectious bronchitis virus (IBV), strain M41. Spleen cells, expanded in vitro by stimulation with M41, were immortalized by fusion to obtain T-cell hybridomas, and two major histocompatability complex (MHC) class II (I-E)-restricted T-cell hybridomas were selected with specificity for IBV. Both hybridomas selectively recognized the internal nucleocapsid protein. The responses to 12 different strains of IBV varied markedly. This demonstrates antigenic variation of the nucleocapsid protein in addition to the known variation of the surface glycoprotein S.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847691      PMCID: PMC1384328     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Induction of protective immunity against rabies by immunization with rabies virus ribonucleoprotein.

Authors:  B Dietzschold; H H Wang; C E Rupprecht; E Celis; M Tollis; H Ertl; E Heber-Katz; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Synthesis of subgenomic mRNA's of mouse hepatitis virus is initiated independently: evidence from UV transcription mapping.

Authors:  L Jacobs; W J Spaan; M C Horzinek; B A van der Zeijst
Journal:  J Virol       Date:  1981-08       Impact factor: 5.103

3.  Coronavirus IBV glycopolypeptides: size of their polypeptide moieties and nature of their oligosaccharides.

Authors:  D Cavanagh
Journal:  J Gen Virol       Date:  1983-05       Impact factor: 3.891

4.  Coronavirus IBV: further evidence that the surface projections are associated with two glycopolypeptides.

Authors:  D Cavanagh
Journal:  J Gen Virol       Date:  1983-08       Impact factor: 3.891

5.  Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid.

Authors:  L S Sturman; K V Holmes; J Behnke
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

Review 6.  Rat X mouse T-cell hybrids with inducible specific cytolytic activity.

Authors:  A Silva; H R MacDonald; A Conzelmann; P Corthésy; M Nabholz
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

7.  Coronavirus multiplication: locations of genes for virion proteins on the avian infectious bronchitis virus genome.

Authors:  D F Stern; B M Sefton
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

8.  Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells.

Authors:  A R Townsend; A J McMichael; N P Carter; J A Huddleston; G G Brownlee
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

9.  In vitro influenza virus-specific antibody production in man: antigen-specific and HLA-restricted induction of helper activity mediated by cloned human T lymphocytes.

Authors:  J R Lamb; J N Woody; R J Hartzman; D D Eckels
Journal:  J Immunol       Date:  1982-10       Impact factor: 5.422

10.  Thymus dictates major histocompatibility complex (MHC) specificity and immune response gene phenotype of class II MHC-restricted T cells but not of class I MHC-restricted T cells.

Authors:  W M Kast; L P de Waal; C J Melief
Journal:  J Exp Med       Date:  1984-12-01       Impact factor: 14.307

View more
  10 in total

1.  Specific cytotoxic T lymphocytes are involved in in vivo clearance of infectious bronchitis virus.

Authors:  S H Seo; E W Collisson
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus.

Authors:  A M Boots; J G Kusters; J M van Noort; K A Zwaagstra; E Rijke; B A van der Zeijst; E J Hensen
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

3.  A Novel Immunochromatographic Strip for Antigen Detection of Avian Infectious Bronchitis Virus.

Authors:  I-Li Liu; Yi-Chun Lin; Yong-Chong Lin; Cai-Zhen Jian; Ivan-Chen Cheng; Hui-Wen Chen
Journal:  Int J Mol Sci       Date:  2019-05-06       Impact factor: 5.923

4.  Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies.

Authors:  I M Antón; S González; M J Bullido; M Corsín; C Risco; J P Langeveld; L Enjuanes
Journal:  Virus Res       Date:  1996-12       Impact factor: 3.303

5.  Variations in the nucleocapsid protein gene of infectious bronchitis viruses isolated in Korea.

Authors:  Ji Yeun Park; Son Il Pak; Haan Woo Sung; Jae Hong Kim; Chang Seon Song; Chang Won Lee; Hyuk Moo Kwon
Journal:  Virus Genes       Date:  2005-10       Impact factor: 2.332

6.  Protection against avian coronavirus conferred by oral vaccination with live bacteria secreting LTB-fused viral proteins.

Authors:  Avishai Lublin; Chen Katz; Nady Gruzdev; Itamar Yadid; Itai Bloch; Yigal Farnoushi; Luba Simanov; Asaf Berkowitz; Dalia Elyahu; Jacob Pitcovski; Ehud Shahar
Journal:  Vaccine       Date:  2021-12-30       Impact factor: 3.641

7.  A Novel Nanobody-Horseradish Peroxidase Fusion Based-Competitive ELISA to Rapidly Detect Avian Corona-Virus-Infectious Bronchitis Virus Antibody in Chicken Serum.

Authors:  Kui Gu; Zengxu Song; Peng Ma; Ziwei Liao; Ming Yang; Changyu Zhou; Chao Li; Yu Zhao; Hao Li; Xin Yang; Changwei Lei; Hongning Wang
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

8.  Comparative analyses of the nucleocapsid genes of several strains of infectious bronchitis virus and other coronaviruses.

Authors:  A K Williams; L Wang; L W Sneed; E W Collisson
Journal:  Virus Res       Date:  1992-09-15       Impact factor: 3.303

9.  Induction of anti-viral immune responses by immunization with recombinant-DNA encoded avian coronavirus nucleocapsid protein.

Authors:  A M Boots; B J Benaissa-Trouw; W Hesselink; E Rijke; C Schrier; E J Hensen
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

10.  The Efficacy of a Live Attenuated TW I-Type Infectious Bronchitis Virus Vaccine Candidate.

Authors:  Xinheng Zhang; Tong Chen; Sheng Chen; Yu Nie; Zi Xie; Keyu Feng; Huanmin Zhang; Qingmei Xie
Journal:  Virol Sin       Date:  2021-07-12       Impact factor: 4.327

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.